Location History:
- Miyagi, JP (2020)
- Sendai, JP (2020 - 2022)
Company Filing History:
3 out of 993 
2 out of 47 
2 out of 1,295 
Years Active: 2020-2022
Title: Hidetoshi Tokuyama: Innovator in Intracellular Delivery and Pulmonary Hypertension Treatment
Introduction
Hidetoshi Tokuyama is a notable inventor based in Sendai, Japan. He has made significant contributions to the fields of intracellular delivery systems and therapeutic agents for pulmonary hypertension. With a total of three patents to his name, Tokuyama's work is recognized for its innovative approaches to complex medical challenges.
Latest Patents
One of Tokuyama's latest patents is an intracellular delivery vehicle designed to facilitate the transport of desired components or compounds into cells. This vehicle features a positively charged surface, which enhances its ability to deliver materials without inhibiting cell proliferation. Additionally, he has developed a temperature-sensitive probe that utilizes this delivery complex, allowing for the measurement of intracellular temperature. Another significant patent addresses pulmonary hypertension, providing a novel preventative or therapeutic agent that includes emetine or its salts as an active ingredient. This invention aims to offer new treatment options for a condition that has previously lacked effective therapeutic agents.
Career Highlights
Hidetoshi Tokuyama has worked with esteemed institutions such as Tohoku University and Kirin Holdings Company. His research and innovations have contributed to advancements in medical science, particularly in drug delivery systems and treatments for pulmonary conditions.
Collaborations
Throughout his career, Tokuyama has collaborated with notable colleagues, including Toshikazu Tsuji and Kumiko Ikado. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in his field.
Conclusion
Hidetoshi Tokuyama's contributions to the fields of intracellular delivery and pulmonary hypertension treatment exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to advancing healthcare solutions that can significantly improve patient outcomes.